By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Gen-Probe announced after the close of market on Tuesday that it has filed a Premarket Approval application with the US Food and Drug Administration for its prostate cancer assay.

The test, called Progensa PCA3, may help in determining whether repeat biopsies are needed in men suspected of having prostate cancer, Gen-Probe said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: biobank of colorectal cancer organoids, ancient wolf genome analysis, and more.

With cloud computing becoming more attractive to researchers, Nature News offers some tips on how to get going.

In a series of articles, medical journals debate the necessity of conflict-of-interest policies.

Irwin Rose, who won the 2004 Nobel Prize in Chemistry for his work on ubiquitin-mediated protein degradation, has died.